A USF researcher led a clinical trial for a new Parkinson’s drug
A new drug that can prevent the symptoms of Parkinson’s disease longer than existing drugs has just hit the market.
Read MoreA new drug that can prevent the symptoms of Parkinson’s disease longer than existing drugs has just hit the market.
Read MoreThe $10 million funding round was led by Rahal and Valor Siren Ventures, in addition to Peter Attia, a Stanford,
Read More